128162-62-9 Usage
General Description
The chemical compound "({[(5S,6S)-1,6,9,14-tetrahydroxy-5-{[(2S,3R,4S,5S,6S)-3-hydroxy-6-(hydroxymethyl)-5-(methylamino)-4-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetrac" is a highly complex molecule with multiple hydroxyl and methoxy groups as well as multiple ring structures. ({[(5S,6S)-1,6,9,14-tetrahydroxy-5-{[(2S,3R,4S,5S,6S)-3-hydroxy-6-(hydroxymethyl)-5-(methylamino)-4-{[(2S,3R,4S,5R)-3,4,5-trihydroxytetrahydro-2H-pyran-2-yl]oxy}tetrahydro-2H-pyran-2-yl]oxy}-11-methoxy-3-methyl-8,13-dioxo-5,6,8,13-tetrahydrobenzo[a]tetrac is a tetracyclic polyketide that exhibits a high degree of stereochemical complexity with a variety of functional groups such as hydroxyl, methoxy, and methylamino. The compound's structure suggests that it may have potential pharmaceutical or biological activity, and further research may be required to elucidate its full chemical and biological properties.
Check Digit Verification of cas no
The CAS Registry Mumber 128162-62-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,8,1,6 and 2 respectively; the second part has 2 digits, 6 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 128162-62:
(8*1)+(7*2)+(6*8)+(5*1)+(4*6)+(3*2)+(2*6)+(1*2)=119
119 % 10 = 9
So 128162-62-9 is a valid CAS Registry Number.
128162-62-9Relevant articles and documents
Pradimic acids, amides, and pradimicin derivatives
-
, (2008/06/13)
The present invention relates to intermediates, pradimic acids and pradimic acid amides of the formula (II) STR1 wherein R is OH or NH2 ; R1 is hydrogen or a group of the formula STR2 with the proviso that when R is OH, R1 is not hydrogen; Y is OH or NR2 R3 ; R2 is hydrogen or methyl; R3 is hydrogen, C1-5 alkyl, or an amino protecting group; R4 is hydrogen, hydroxy protecting group, or β-D-xylosyl. The invention relates also to novel processes for the preparation of pradimic acids and pradimic acid amides, as well as novel pradimicin derivatives prepared therefrom.
